NCT01961583View on ClinicalTrials.gov

[18F]Fluciclatide PET Imaging of Pazopanib Response

PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Kidney Neoplasm
Interventions
DRUG

18F-Fluciclatide

"Baseline 18F-Fluciclatide PET imaging will be obtained before starting of Pazopanib therapy(within 7 days).~Subsequent 18F-Fluciclatide PET should be performed on 7 days after Pazopanib therapy"

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Asan Medical Center

OTHER